Very excited to see our story online in Nucleic Acids Res!🎉 We found plasmids in nature carry a fascinating diversity of CRISPR-Cas🌈🤯 We characterized their abundance, diversity, distribution & investigated their CRISPR contents to infer their function(s)!! academic.oup.com/nar/advance-ar…

This tale of a hardworking microbe is no longer a preprint 🙌 nature.com/articles/s4146… Lotta-Riina Sundberg Gabriel MF Almeida

Check out our work on a new antivirus signaling molecule found in type III CRISPR-Cas systems. Thank you @Skr_fi for supporting the project 🎉

Four PhD positions available in ⁦University of Jyväskylä⁩ Finland, one of these in my research group! The topic is phage-bacterium interaction using environmental isolates, highly motivated candidates encouraged to apply! ats.talentadore.com/apply/doctoral…

PrecisionPhage is excited to soon announce the launch of our Software-as-a-Service platform – Phagenomics - designed to transform bacteriophage-related bioinformatics. The platform works also as a comprehensive database for your phage and host collection. phagenomics.net

PrecisionPhage took part in the Tahko Ski Lift Pitch - an energising 2-day pitching event with an outstanding startup line-up - organised by Kuopio Region Chamber of Commerce. We are pleased to announce that our CEO Matti Jalasvuori rode through he*l and won the contest! 🚀

✨Phage therapy news! We are happy to share that phages from PrecisionPhage were successfully used to treat recurrent sepsis caused by Pseudomonas aeruginosa. 🔗Read the article here: mdpi.com/2079-6382/13/1…

A 75-year-old female patient w/ recurrent Pseudomonas septicaemia & arterial stents was treated using a #phage–meropenem combination therapy at Tampere University Hospital, Finland with great success. buff.ly/3TO5vU4